Phibro Animal Health Corporation (NASDAQ:PAHC) Given Average Recommendation of "Reduce" by Brokerages

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) have earned a consensus rating of "Reduce" from the six brokerages that are covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $24.40.

PAHC has been the subject of several research reports. Morgan Stanley set a $26.00 price objective on Phibro Animal Health and gave the stock an "equal weight" rating in a research note on Wednesday, June 25th. BNP Paribas Exane raised Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective for the company in a research note on Monday, June 16th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $25.00 to $35.00 in a research note on Monday. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Finally, Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th.

Institutional Investors Weigh In On Phibro Animal Health

A number of hedge funds have recently modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Phibro Animal Health by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock valued at $32,500,000 after buying an additional 6,784 shares during the period. Acadian Asset Management LLC lifted its holdings in Phibro Animal Health by 0.5% in the first quarter. Acadian Asset Management LLC now owns 782,939 shares of the company's stock valued at $16,713,000 after acquiring an additional 4,144 shares during the last quarter. American Century Companies Inc. lifted its holdings in Phibro Animal Health by 18.0% in the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock valued at $13,348,000 after acquiring an additional 96,787 shares during the last quarter. Nuveen Asset Management LLC grew its position in Phibro Animal Health by 21.4% in the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after acquiring an additional 103,618 shares during the period. Finally, Renaissance Technologies LLC increased its stake in Phibro Animal Health by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company's stock worth $11,714,000 after acquiring an additional 10,600 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Price Performance

Shares of Phibro Animal Health stock traded down $0.34 on Friday, hitting $30.80. The company's stock had a trading volume of 330,261 shares, compared to its average volume of 305,369. The company has a market capitalization of $1.25 billion, a price-to-earnings ratio of 16.14, a price-to-earnings-growth ratio of 0.52 and a beta of 0.75. The firm has a fifty day moving average price of $24.79 and a 200-day moving average price of $22.44. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91. Phibro Animal Health has a 1 year low of $16.16 and a 1 year high of $31.80.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. The company had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. As a group, sell-side analysts anticipate that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 1.56%. Phibro Animal Health's dividend payout ratio is presently 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.